HCV Advocate - Journal Review Feb 2007

Posted: 22-Feb-2007 << BACK

A Review of HCV, HBV and HIV/HCV Coinfection Related News and Highlights
Week Ending: February 17th , 2007
Download the PDF file below to read the articles

Better Infection Control Programs Needed to Help Combat Hepatitis C in Egypt
Hepatitis C Rates Soar in Sydney Addicts
'One-Third' of Prisoners Have Hep C
Onyx's Liver-Cancer Drug Blew Away Trial Goals
FDA Restricts Drug Used to Treat Bronchitis after Deaths, Severe Liver Problems Reported
Chronic Hepatitis C Tracking Urged
Vertex Optimistic on Hepatitis C Drug
Blood Test Index May Help Liver Patients Avoid Biopsy
Virological Response Improves Quality of Life in Hep C with Fibrosis
Low Prothrombin Index an Indicator for Emergency Liver Transplant
Who Owns Your Genes?
Transgene Initiates A Phase I Trial of its Therapeutic Vaccine Candidate TG4040 for Patients Chronically Infected With the Hepatitis C Virus
Among Chinese, Fear and Prejudice about Hepatitis B
Body Shop's Roddick has Hepatitis C
Quebec is the First Province in Canada to Reimburse New Drug Developed to Treat Chronic Hepatitis B
Blood Tests Perform Similarly at Staging Liver Fibrosis in HCV
Peregrine Pharmaceuticals Reports Positive Phase Ib Results for Its Targeted Immunotherapy Bavituximab in Chronic Hepatitis C Infection
Transgene Starts Enrollment in Hepatitis Trial
Hepatitis C Cases in Macedonia on Rise
McGuinty Government Invests in Nursing Support Program for Hepatitis C Patients

Attachment: HCV Advocate Journal Review Feb 17th 2007.pdf